European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up

NCT04017325 · clinicaltrials.gov ↗

COMPLETED

Status

374

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Prostate

Interventions

OTHER: no intervention (post study follow up)

Sponsor

Steba Biotech S.A.

Collaborators

[object Object]
[object Object]